A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment

Toxicologic Pathology

Volumn 25, Issue 3, 1997, Pages 291-307

  Morgan, Kevin T ^{a,b,c,d,e,f,g,h}  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Moredun Sheep Diseases Res Inst   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Battelle Geneva Research Center   (Switzerland)

^f National Center for Toxicology Research   (United States)

^g Royal College of Pathologists   (United Kingdom)

^h GLAXOSMITHKLINE   (United States)

Author keywords

Airflow; Animal models; DNA protein cross links; Dosimetry; Metabolism; Physiology

Indexed keywords

DNA; FORMALDEHYDE;

BLOOD FLOW; CANCER RISK; CARCINOGENESIS; HEALTH HAZARD; HUMAN; NONHUMAN; NOSE AIRFLOW; NOSE CARCINOMA; NOSE TUMOR; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; RAT; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ANIMALIA; RODENTIA;

EID: 0030914842     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339702500307     Document Type: Review

References (142)

1. American Conference of Governmental Industrial Hygienists (1995). 1995-1996 Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. American Conference of Governmental Industrial Hygienists, Cincinnati, Ohio.
2. Albert RE, Sellakumar AR, Laskin S, Kuschner M, Nelson N, and Snyder CA (1982). Gaseous formaldehyde and hydrogen chloride induction of nasal cancer in the rat. J. Natl. Cancer Inst. 68: 597-603.
3. Appelman LM, Woutersen RA, Zwart A, Falke HE, and Feron VJ (1988). One-year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. J. Appl. Toxicol. 8: 85-90.
4. Barrow CS (ed) (1986). Toxicology of the Nasal Passages. Hemisphere Publishing Corporation, New York.
5. Bermudez E, Chen Z, Gross EA, Walker CL, Recio L, Pluta L, and Morgan KT (1994). Characterization of cell lines from formaldehyde-induced nasal tumors in rats. Mol. Carcinog. 9: 193-199.
6. Bogdanffy MS, Morgan PH, Morgan KT, and Starr TB (1986). Binding of formaldehyde to human and rat nasal mucus and bovine serum albumin. Toxicol. Lett. 38: 145-154.
7. Boysen M, Downs AM, Rigatu JP, Torjussen W, Hogetveit AC, Andersen I, Berge SR, Solberg LA, Abeler VM, and Reith A (1994). Rates of regression and progression of dysplastic lesions in the nasal mucosa in nickel workers: A Markov model approach. Sci. Total Environ. 148: 311-318.
8. Brown HR, Monticello TM, Maronpot RR, Randall HW, Hotchkiss JR, and Morgan KT (1991). Proliferative and neoplastic lesions in the rodent nasal cavity. Toxicol. Pathol. 19: 358-372.
9. Buckley LA, Jiang XZ, James RA, Morgan KT, and Barrow CS (1984). Respiratory tract lesions induced by sensory irritants at the RD50 concentration. Toxicol. Appl. Pharmacol. 74: 417-429.
10. Butterworth BE (1996). Letter to editor. Cancer Res. 56: 4270-4272.
11. Butterworth BE, Conolly RB, and Morgan KT (1995). A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett. 93: 129-146.
12. Butterworth BE, Popp JA, Conolly RB, and Goldsworthy TL (1992). Chemically induced cell proliferation in carcinogenesis. In: Mechanisms of Carcinogenesis in Risk Identification, H Vainio, PN Magee, DB McGregor, and AJ McMichael (eds). International Agency for Research on Cancer, Lyon, France, pp. 279-305.
13. Calderon-Garcidueñas L, Osorno-Velazquez A, Bravo-Alvarez H, Delgado-Chavez R, and Barrios-Marquez R (1992). Histopathologic changes of the nasal mucosa in southwest metropolitan Mexico City inhabitants. Am. J. Pathol. 140: 225-232.
14. Casanova M, Deyo DF, and Heck Hd'A (1989). Covalent binding of inhaled formaldehyde to DNA in the nasal mucosa of Fischer-344 rats: Analysis of formaldehyde and DNA by high-performance liquid chromatography and provisional pharmacokinetic interpretation. Fundam. Appl. Toxicol. 12: 397-417.
15. Casanova M and Heck Hd'A (1997). Metabolism of Formaldehyde. European Centre for Ecotoxicology and Toxicology of Chemicals, Technical Report (in preparation), Brussels, Belgium.
16. Casanova M, Heck Hd'A, and Janszen D (1996). Comments on 'DNA-protein crosslinks, a biomarker of exposure to formaldehyde - in vitro and in vivo studies' by Shaham et al. Carcinogenesis 17: 2097-2098.
17. Casanova M, Morgan KT, Gross EA, Moss OR, and Heck Hd'A (1994). DNA-protein cross-links and cell replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde. Fundam. Appl. Toxicol. 23: 525-536.
18. Casanova M, Morgan KT, Steinhagen WH, Everitt JI, Popp JA, and Heck Hd'A (1991). Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: Pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man. Fundam. Appl. Toxicol. 17: 409-428.
19. Casanova-Schmitz M, David RM, and Heck Hd'A (1984a). Oxidation of formaldehyde and acetaldehyde by NAD+-dependent dehydrogenases in rat nasal mucosal homogenates. Biochem. Pharmacol. 33: 1137-1142.
20. Casanova-Schmitz M and Heck Hd'A (1983). Effects of formaldehyde exposure on the extractability of DNA from proteins in the rat nasal mucosa. Toxicol. Appl. Pharmacol. 70: 121-132.
21. Casanova-Schmitz M, Starr TB, and Heck Hd'A (1984b). Differentiation between metabolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]- and [H3]formaldehyde. Toxicol. Appl. Pharmacol. 76: 26-44.
22. Chang JCF, Gross EA, Swenberg JA, and Barrow CS (1983). Nasal cavity deposition, histopathology, and cell proliferation after single or repeated formaldehyde exposures in B6C3F1 mice and F-344 rats. Toxicol. Appl. Pharmacol. 68: 161-176.
23. Cohen SM and Ellwein LB (1990). Cell proliferation in carcinogenesis. Science 249: 1007-1011.
24. Cohen-Hubal EAC, Fedkiw PS, and Kimbell JS (1996a). Masstransport models to predict toxicity of inhaled gases in the upper respiratory tract. J. Appl. Physiol. 80: 1415-1427.
25. Cohen-Hubel EA, Kimbell JS, and Fedkiw PS (1996b). Incorporation of nasal-lining mass-transfer resistance into a CFD model for prediction of ozone dosimetry in the upper respiratory tract. Inhal. Toxicol. 8: 831-857.
26. Cohen-Hubel EA, Schlosser PM, Conolly RB, and Kimbell JS (1997). Comparison of inhaled formaldehyde dosimetry predictions with DNA-protein cross-link measurements in the rat upper respiratory tract. Toxicol. Appl. Pharmacol. 143: 47-55.
27. Collins JJ, Acquavella JF, and Esmen NA (1996). Formaldehyde exposure and upper respiratory cancer: An updated review and meta-analysis. Submitted.
28. Conolly RB and Anderson ME (1993). An approach to mechanism-based cancer risk assessment for formaldehyde. Environ. Health Perspect. 101(suppl. 6): 169-176.
29. Conolly RB, Andjelkovich DA, Casanova M, Heck Hd'A , Janszen DB, Kimbell JS, Morgan KT, and Recio L (1995). Multidisciplinary, iterative examination of the mechanism of formaldehyde carcinogenicity: The basis for better risk assessment. CIIT Activities 15: 1-11.
30. Conolly RB, Morgan KT, Andersen ME, Monticello TM, and Clewell HJ (1992). A biologically-based risk assessment strategy for inhaled formaldehyde. Comments Toxicol. 4: 269-293.
31. Coulston F (1993). Editorial. Qual. Ass. Good Pract. Law 2: 211-212.
32. Consumer Product Safety Commission (1982). Ban of urea-formaldehyde foam insulation, withdrawal of proposed information labeling rule, and denial of petition to issue a standard. Fed. Regist. 47(64): 14366.
33. Dahl AR and Hadley WH (1991). Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. Crit. Rev. Toxicol. 21: 345-372.
34. Dasgupta A, Guenard P, Anderson SM, Karsnitz JS, Ultman JS, and Morgan KT (1995). Calibration of a photographic method for imaging mass transfer in aqueous solutions. Int. J. Heat Mass Transfer 38: 2029-2037.
35. DeSesso JM (1993). The relevance to humans of animal models for inhalation studies of cancer in the nose and upper airways. Qual. Ass. Good Pract. Law 2: 213-231.
36. Eccles R (1995). Rhinitis as a mechanism of respiratory defense. Eur. Arch. Otorhinolaryngol. 252(suppl. 1): S2-S7.
37. Eccles R, Bende M, and Widdicombe JG (1987). Nasal blood vessels. In: Allergic and Vasomotor Rhinitis: Pathophysiological Aspects, 1st ed., N Mygind and U Pipkorn (eds). Munksgaard, Copenhagen, Denmark, pp. 63-76.
38. Farber E (1995). Cell proliferation as a major risk factor for cancer: A concept of doubtful validity. Cancer Res. 55: 3759-3762.
39. Farber E (1996). Reply to letter to editor. Cancer Res. 56: 4272-4274.
40. Feron VJ and Bosland MC (eds) (1989). Nasal Carcinogenesis in Rodents: Relevance to Human Health Risk. Proceedings of the TNO-CIVO/NYU Nose Symposium, October 24-28, 1988, in Pudoc, Wageningen, Veldhoven, Netherlands.
41. Feron VJ, Bruyntjes RA, Wouterson HR, Immel HR, and Appelman LM (1988). Nasal tumours in rats after short-term exposure to a cytotoxic concentration of formaldehyde. Cancer Lett. 39: 101-111.
42. Feron VJ, Til HP, de Vrijer F, Woutersen RA, Cassee FR, and van Bladeren PJ (1991). Aldehydes: Occurrence, carcinogenic potential, mechanism of action and risk assessment. Mut. Res. 259: 363-385.
43. Feron VJ and Woutersen RA (1989). Role of tissue damage in nasal carcinogenesis. In: Nasal Carcinogenesis in Rodents: Relevance to Human Health Risk, VJ Feron and MC Bosland (eds). Pudoc, Wageningen, Veldhoven, Netherlands, pp. 76-84.
44. Frederick CB, Morris JB, Kimbell JS, Morgan KT, Hanna LM, and Scherer PW (1994). Comparison of four biologically-based dosimetry models for the rodent nasal cavity to describe the deposition and distribution of rapidly metabolized vapors. Inhal. Toxicol. 6: 135-157.
45. Gallo MA and Doull J (1996). History and scope of toxicology. In: Casarett and Doull's Toxicology, The Basic Science of Poisons, 5th ed., MO Amdur, J Doull, and CD Klaasen (eds). Pergamon Press, New York, pp. 3-11.
46. Goldsworthy TL, Morgan KT, Popp JA, and Butterworth BE (1991). Guidelines for measuring chemically-induced cell proliferation in specific rodent target organs. In: Chemically-Induced Cell Proliferation: Implications for Risk Assessment. BE Butterworth and TJ Slaga (eds). Wiley, New York, pp. 253-284.
47. Harkema JR (1991). Comparative aspects of nasal airway anatomy: Relevance to inhalation toxicology. Toxicol. Pathol. 19: 321-336.
48. Harkema JR, Lee JK, Morgan KT, and Frederick CB (1997). Olfactory epithelial injury in monkeys after acute inhalation exposure to acrylic monomers. The Toxicologist 36: 113. (abstract 576).
49. Harkema JR and Morgan KT (1996). Normal morphology of the nasal passages in laboratory rodents. In: Monographs on Pathology of Laboratory Animals, Respiratory System, TC Jones, DL Dungworth, and U Mohr (eds). Springer-Verlag, New York, pp. 3-17.
50. Hatch GE (1992). Comparative biochemistry of airway lining fluid. In: Treatise on Pulmonary Toxicology, Comparative Biology of the Normal Lung, Vol. 3, R. Parent (ed). CRC Press, Boca Raton, Louisiana, pp. 617-632.
51. Hayashi S, Kikuta A, Ohtsuka A, and Masuda Y (1991). Microvascular architecture of rat nasal associated lymphoid tissue. Arch. Histol. Cytol. 54: 279-287.
52. Heck Hd'A (1997). Aldehydes. In: Comprehensive Toxicology, Toxicology of the Respiratory Tract, IG Sipes, AJ Gandolfi, and CA McQueen (eds). Elsevier Science, New York (in press).
53. Heck Hd'A , Casanova M, and Starr TB (1990). Formaldehyde toxicity - New understanding. Crit. Rev. Toxicol. 20: 397-426.
54. Heck Hd'A, Casanova-Schmitz M, Dodd PB, Schachter EN, Witek TJ, and Tosun T (1985). Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am. Ind. Hyg. Assoc. J. 46: 1-3.
55. Hernandez O, Rhomberg L, Hogan K, Siegel-Scott C, Lai D, Grindstaff G, Henry M, and Cotruvo JA (1994). Risk assessment of formaldehyde. J. Hazard. Mater. 39: 161-172.
56. Holmström M, Rynnel-Dagoo B, and Wilhelmsson B (1989). Antibody production in rats after long-term exposure to formaldehyde. Toxicol. Appl. Pharmacol. 100: 328-333.
57. Internal Agency for Research on Cancer (1995). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 62, Wood Dust and Formaldehyde. World Health Organization, Geneva, Switzerland.
58. Ibanes JD, Leininger JR, Jarabek AM, Harkema JR, Hotchkiss JA, and Morgan KT (1996). Reexamination of respiratory tract responses in rats, mice and rhesus monkeys chronically exposed to inhaled chlorine. Inhal. Toxicol. 8: 859-876.
59. Jarabek AM (1994). Inhalation RfC methodology: Dosimetric adjustments and dose-response estimation of noncancer toxicity in the URT. Inhal. Toxicol. 6: 301-325.
60. Keller DA, Heck Hd'A, Randall HW, and Morgan KT (1990). Histochemical localization of formaldehyde dehydrogenase in the rat. Toxicol. Appl. Pharmacol. 106: 311-326.
61. Kepler GM, Joyner DR, Fleishman A, Richardson R, Gross EA, Morgan KT, and Kimbell JS (1995). Method for obtaining accurate geometrical coordinates of nasal airways for computer dosimetry modeling and lesion mapping. Inhal. Toxicol. 1: 1207-1224.
62. Kepler GM, Richardson RR, Morgan KT, and Kimbell JS (1997). Computer simulation of nasal airflow in a rhesus monkey. Submitted.
63. Kerns WD (1985). Polypoid adenoma of the nasal cavity in the laboratory rat. In: Monographs of Pathology of Laboratory Animals, Respiratory System, TC Jones, U Mohr, RD Hunt (eds). Springer-Verlag, New York, pp. 41-47.
64. Kerns WD, Pavkov KL, Donofrio DJ, Gralla EJ, and Swenberg JA (1983). Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43: 4382-4398.
65. Keyhani K, Scherer PW, and Mozell MM (1995). Numerical simulation of airflow in the human nasal cavity. J. Biomech. Eng. 117: 429-441.
66. Kimbell JS, Godo MN, Gross EA, Joyner DR, Richardson RB, and Morgan KT (1996). Simulation of respiratory airflow in the olfactory region of the F344 rat nasal passages. Toxicologist 30: 99.
67. Kimbell JS, Godo MN, Gross EA, Joyner DR, Richardson RB, and Morgan KT (1997a). Computer simulation of inspiratory airflow in all regions of the F344 rat nasal passages. Toxicol. Appl. Pharmacol. (in press).
68. Kimbell JS, Gross EA, Joyner DR, Godo MN, and Morgan KT (1993). Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat. Toxicol. Appl. Pharmacol. 121: 253-263.
69. Kimbell JS, Gross EA, Richardson RB, Conolly RB, and Morgan KT (1997b). Correlation of regional formaldehyde flux predictions with the distribution of formaldehyde-induced squamous metaplasia in F344 rat nasal passages. Mutat. Res. (in press).
70. Kimbell JS, Kepler GM, and Morgan KT (1995). Three-dimensional, steady-state inspiratory airflow simulations in rhesus monkey nasal passages. J. Aerosol Med. 8: 64 (abstract).
71. Klaassen CDE (1996). Casarett and Doull's Toxicology, The Basic Science of Poisons, 5th ed. McGraw-Hill, New York.
72. Klonne DR, Ulrich CE, Riley MG, Hamm TEJ, Morgan KT, and Barrow CS (1987). One-year inhalation toxicity study of chlorine in rhesus monkeys (Macaca mulatta). Fundam. Appl. Toxicol. 9: 557-572.
73. Larson JL, Wolf DC, Mery S, Morgan KT, and Butterworth BE (1994). Toxicity and cell proliferation in the liver, kidneys and nasal passages of female F-344 rats, induced by chloroform administered by gavage. Food Chem. Toxicol. 33: 443-456.
74. Latendresse JR, Marit GB, Vernot EH, Haun CC, and Carlyle DF (1995). Oncogenic potential of inhaled hydrazine in the nose of rats and hamsters after one or ten one-hour exposures. Fundam. Appl. Toxicol. 27: 33-48.
75. Leininger J, Gross EA, Monticello TM, Seilkop S, Calderon-Garciduenas L, and Morgan KT (1994). The morphogenesis of formaldehyde-induced nasal neoplasia. In preparation.
76. Leopold DA (1994). Nasal toxicity: End points of concern in humans. Inhal. Toxicol. 6: 23-39.
77. Lomax LG, Brown DW, and Frederick CB (1994). Regional histopathology of the mouse nasal cavity following two weeks of exposure to acrylic acid for either 6 or 22 hours per day. Inhal. Toxicol. 6: 445-449.
78. Maran GD and Lund VJ (1990). Clinical Rhinology. Thieme Medical Publishers, Inc., New York.
79. Maronpot RR, Miller RA, Clarke WJ, Westerberg RB, Decker JR, and Moss OR (1986). Toxicity of formaldehyde vapor in B6C3F1 mice exposed for 13 weeks. Toxicology 41: 253-266.
80. McClellan RO (1994). Research strategy for assessing human risk from inhaled nasal toxicants. Inhal. Toxicol. 6: 11-21.
81. Méry S, Gross EA, Joyner DR, Godo M, and Morgan KT (1994a). Nasal diagrams: A tool for recording the distribution of nasal lesions in rats and mice. Toxicol. Pathol. 22: 353-372.
82. Méry S, Larson JL, Butterworth BE, Wolf DC, Harden R, and Morgan KT (1994b). Nasal toxicity of chloroform in male F-344 rats and female B6C3F1 mice following a 1-week inhalation exposure. Toxicol. Appl. Pharmacol. 125: 214-227.
83. Miller F (1994). Nasal toxicity and dosimetry of inhaled xenobiotics: Implications for human health. Inhal. Toxicol. 6: 1-469.
84. Miller RR, Ayres JA, Jersey GC, and McKenna MJ (1981). Inhalation toxicity of acrylic acid. Fundam. Appl. Toxicol. 1: 271-277.
85. Monticello TM, Miller FJ, and Morgan KT (1991a). Regional increases in rat nasal respiratory epithelial cell proliferation following acute and subacute inhalation of formaldehyde. Toxicol. Appl. Pharmacol. 111:409-421.
86. Monticello TM and Morgan KT (1990). Correlation of cell proliferation and inflammation with nasal tumors in F-344 rats following chronic formaldehyde exposure. Carcinogenesis 31: 139 (abstract 826).
87. Monticello TM, Morgan KT, Everitt JI, and Popp JA (1989). Effects of formaldehyde gas on the respiratory tract of rhesus monkeys: Pathology and cell proliferation. Am. J. Pathol. 134: 515-527.
88. Monticello TM, Morgan KT, and Hurtt M (1990). Unit length as the denominator for quantitation of cell proliferation rate in nasal epithelium. Toxicol Pathol. 18: 24-31.
89. Monticello TM, Renne R, and Morgan KT (1991b). Chemically-induced cell proliferation in upper respiratory tract carcinogenesis. In: Chemically-Induced Cell Proliferation: Implications for Risk Assessment, BE Butterworth and TJ Slaga (eds). Wiley-Liss, Inc., New York, pp. 323-335.
90. Monticello TM, Swenberg JA, Gross EA, Leininger JR, Kimbell JS, Seilkop S, Starr TB, Gibson JE, and Morgan KT (1996). Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res. 56: 1012-1022.
91. Moolgavkar SH, Dewanji A, and Venzon DJ (1988). A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor. Risk Anal. 8: 383-392.
92. Morgan KT (1994). Nasal dosimetry, lesion distribution, and the toxicologic pathologist: A brief review. Inhal. Toxicol. 6: 41-57.
93. Morgan KT, Gross EA, Joyner D, and Méry S (1995). Mapping of lesions in the nose provides insight into mechanism of action of nasal toxicants. CIIT Activities 15: 1-10.
94. Morgan KT, Gross EA, Joyner DR, Ishmael J, and Thake D (1997). Proliferative nasal lesions induced in rats by alachlor, acetochlor and butachlor originate in specific regions of the olfactory mucosa. The Toxicologist 36: 112 (abstract 575).
95. Morgan KT, Gross EA, and Patterson DL (1986a). Distribution, progression, and recovery of acute formaldehyde-induced inhibition of nasal mucociliary function in F-344 rats. Toxicol. Appl. Pharmacol. 86: 448-456.
96. Morgan KT, Jiang XZ, Patterson DL, and Gross EA (1984a). The nasal mucociliary apparatus: Correlation of structure and function in the rat. Am. Rev. Respir. Dis. 130: 275-281.
97. Morgan KT, Jiang XZ, Starr TB, and Kerns WD (1986b). More precise localization of nasal tumors associated with chronic exposure of F-344 rats to formaldehyde gas. Toxicol. Appl. Pharmacol. 82: 264-271.
98. Morgan KT, Kimbell JS, Monticello TM, Patra AL, and Fleishman A (1991). Studies of inspiratory airflow patterns in the nasal passages of the F344 rat and rhesus monkey using nasal molds: Relevance to formaldehyde toxicity. Toxicol. Appl. Pharmacol. 110: 223-240.
99. Morgan KT and Monticello TM (1990a). Airflow, gas deposition, and lesion distribution in the nasal passages. Environ. Health Perspect. 85: 209-218.
100. Morgan KT and Monticello TM (1990b). Formaldehyde toxicity: Respiratory epithelial injury and repair. In: Biology, Toxicology, and Carcinogenesis of Respiratory Epithelium, DG Thomassen and P Nettesheim (eds). Hemisphere, New York, pp. 155-171.
101. Morgan KT, Patterson DL, and Gross EA (1984b). Frog palate mucociliary apparatus: Structure, function and response to formaldehyde gas. Fundam. Appl. Toxicol. 4: 58-68.
102. Morgan KT, Patterson DL, and Gross EA (1986c). Responses of the nasal mucociliary apparatus of F-344 rats to formaldehyde gas. Toxicol. Appl. Pharmacol. 82: 1-13.
103. Morgan KT, Patterson DL, and Gross EA (1986d). Responses of the nasal mucociliary apparatus to airborne irritants. In: Toxicology of the Nasal Passages, CS Barrow (ed). Hemisphere Publishing Corporation, New York, pp. 123-133.
104. Morris JB (1997). Uptake of acetaldehyde vapor and aldehyde dehydrogenase levels in the upper respiratory tracts of the mouse, rat, hamster, and guinea pig. Fundam. Appl. Toxicol. 35: 91-100.
105. Morris JB, Hassett DN, and Blanchard KT (1993). A physiologically based pharmacokinetic model for nasal uptake and metabolism of nonreactive vapors. Toxicol. Appl. Pharmacol. 123: 120-129.
106. Negus V (1958). The Comparative Anatomy and Physiology of the Nose and Paranasal Sinuses. Livingstone, Edinburgh and London.
107. Nikula KJ and Lewis JL (1994). Olfactory mucosal lesions in F344 rats following inhalation exposure to pyridine at threshold limit value concentrations. Fundam. Appl. Toxicol. 23: 510-517.
108. Office of Environmental Health Hazard Assessment (1992). Cancer Risk Assessment for Airborne Formaldehyde. Office of Environmental Health Hazard Assessment, Air Toxicology and Epidemiology Section, Washington, D.C.
109. Phipps RJ (1981). The airway mucociliary system. In: Respiratory Physiology III, JG Widdicombe (ed). International Review of Physiology, University Park Press, Baltimore, pp. 213-260.
110. Plopper CG, Harkema JR, Last JA, Pinkerton KE, Tyler WS, St George JA, Wong VJ, Nishio SJ, Weir AS, Dungworth DL, Barry BE, and Hyde DM (1991). The respiratory system of nonhuman primates responds more to ambient concentration of ozone than does that of rats. In: Tropospheric Ozone and the Environment: Papers from an International Conference, RL Berglund, DR Lawson. DJ McKee (eds). Air & Waste Management Association, Pittsburgh, Pennsylvania, pp. 137-150.
111. Proctor DF and Andersen I (eds) (1982). The Nose, Upper Airway Physiology and the Atmospheric Environment. Elsevier Biomedical Press, New York.
112. Proetz AW (1951). Air currents in the upper respiratory tract and their clinical importance. Ann. Otol. Rhinol. Laryngol. 60: 439-467.
113. Recio L, Sisk S, Pluta L, Bermudez E, Gross EA, Chen Z, Morgan KT, and Walker C (1992). p53 Mutations in formaldehyde-induced nasal squamous cell carcinomas in rats. Cancer Res. 52: 6113-6116.
114. Reed CJ (1993). Drug metabolism in the nasal cavity: Relevance to toxicology. Drug Metab. Rev. 25: 173-205.
115. Scherer PW, Keyhani K, and Mozell MM (1994). Nasal dosimetry modeling for humans. Inhal. Toxicol. 6: 85-97.
116. Shaham J, Bomstein Y, Meltzer A, Kaufman Z, Palma E, and Ribak J (1996a). DNA-protein crosslinks, a biomarker of exposure to formaldehyde - In vitro and in vivo studies. Carcinogenesis 17: 121-125.
117. Shaham J, Bomstein Y, Meltzer A, and Ribak J (1996b). Response (letter to the editor). Carcinogenesis 17: 2098-2101.
118. Sigma CC (1996). Material Safety Data Sheet for Formaldehyde, Catalogue Number F1268. Sigma Chemical, St. Louis, Missouri, pp. 1-6.
119. Starr TB, Gibson JE, Barrow CS, Boreiko CJ, Heck Hd'A, Levine RJ, Morgan KT, and Swenberg JA (1985). Estimating human cancer risk from formaldehyde. Critical Issues. In: Formaldehyde: Analytical Chemistry and Toxicology, Advances in Chemistry, Series 210, V Turoski (ed). American Chemical Society, Washington, D.C. pp. 300-333.
120. Stott WT, Dryzga MD, and Ramsey JC (1983). Blood-flow distribution in the mouse. J. Appl. Toxicol. 3: 310-312.
121. Subramaniam RP, Morgan KT, and Kimbell JS (1996). Modeling airflow in the upper respiratory tract: Delivery of xenobiotics to the nasopharynx. Ann. Biomed. Eng. 24(suppl. 1): S-82 (abstract 487).
122. Swenberg JA, Barrow CS, Morgan KT, Heck Hd'A, Boreiko CJ, Levine RJ, and Starr TB (1983a). Non-linear biological responses to formaldehyde and their implications for carcinogenic risk assessment. Carcinogenesis 4: 945-952.
123. Swenberg JA, Gross EA, Martin J, and Popp JA (1983b). Mechanisms of formaldehyde toxicity. In: Formaldehyde Toxicity, JE Gibson (ed). Hemisphere, Washington, D.C., pp. 132-147.
124. Swenberg JA, Kerns WD, Mitchell RI, Gralla EJ, and Pavkov KL (1980). Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor. Cancer Res. 40: 3398-3402.
125. Swift DL and Proctor DF (1977). Access of air to the respiratory tract. In: Respiratory Defense Mechanisms, JD Brain, DF Proctor, and LM Reid (eds). Dekker, New York, pp. 63-93.
126. Templin MV, Larson JL, Butterworth BE, Jamison KC, Leininger JR, Méry S, Morgan KT, Wong BA, and Wolf DC (1996). A 90-day chloroform inhalation study in F-344 rats: Profile of toxicity and relevance to cancer studies. Fundam. Appl. Toxicol. 32: 109-125.
127. Thornton-Manning JR, Nikula KJ, Hotchkiss JA, Avila KJ, Rohrbacher KD, Ding X, and Dahl AR (1997). Nasal cytochrome P450 2A: Identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen. Toxicol. Appl. Pharmacol. 142: 22-30.
128. Universities Associated for Research and Education in Pathology, Inc. (1988). Epidemiology of chronic occupational exposure to formaldehyde: Report of the ad hoc panel on health aspects of formaldehyde. Toxicol. Ind. Health 4: 77-90.
129. Uriah LC and Maronpot RR (1990). Normal histology of the nasal cavity and application of special techniques. Environ. Health Perspect. 85: 187-208.
130. Uriah LC, Morgan KT, and Maronpot RR (1990). Symposium on toxicologic pathology of the upper respiratory system. Environ. Health Perspect. 85: 161-352.
131. U.S. EPA (1996). Proposed Guidelines for Carcinogen Risk Assessment. U.S. Environmental Protection Agency, Washington, D.C.
132. Van Dyke M (1982). An Album of Fluid Motion. The Parabolic Press, Stanford, California.
133. Vogel S (1994). Life in Moving Fluids, 2nd ed. Princeton University Press, Princeton, New Jersey.
134. Wilmer JW, Woutersen RA, Appelman LM, Leeman WR, and Feron VJ (1987). Subacute (4-week) inhalation toxicity study of formaldehyde in male rats: 8-hour intermittent versus 8-hour continuous exposures. J. Appl. Toxicol. 7: 15-16.
135. Wolf DC, Gross EA, Lyght O, Bermudez E, Recio L, and Morgan KT (1995a). Immunohistochemical localization of p53, PCNA and TGF-alpha proteins in formaldehyde-induced rat nasal squamous cell carcinomas. Toxicol. Appl. Pharmacol. 132: 27-35.
136. Wolf DC, Morgan KT, Gross EA, Barrow C, Moss OR, James RA, and Popp JA (1995b). Two-year inhalation exposure of B6C3F1 mice and F344 rats to chlorine induces nasal lesions confined to the nose. Fundam. Appl. Toxicol. 24: 111-131.
137. Woutersen RA and Feron VJ (1989). Localization of nasal tumors in rats exposed to acetaldehyde or formaldehyde. In: Nasal Carcinogenesis in Rodents: Relevance to Human Health Risk, VJ Feron and MC Bosland (eds). Pudoc Press, Wageningen, Netherlands pp. 70-75.
138. Woutersen RA, van Garderen-Hoetmer A, Bruijntjes JP, Zwart A, and Feron J (1989). Nasal tumors in rats after severe injury to the nasal mucosa and prolonged exposure to 10 ppm formaldehyde. J. Appl. Toxicol. 9: 39-46.
139. Young JT (1981). Histopathologic examination of the rat nasal cavity. Fundam. Appl. Toxicol. 1: 309-312.
140. Yuasa T (1991). Stereographic demonstration of the nasal cavity of the rat with reference to the density of blood vessels. Acta Anat. Nippon 66: 191-200.
141. Yuspa SH (1994). The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis. Cancer Res. 54: 1178-1189.
142. Zwart A, Woutersen RA, Wilmer JW, Spit BJ, and Feron VJ (1988). Cytotoxic and adaptive effects in rat nasal epithelium after 3-day and 13-week exposure to low concentrations of formaldehyde vapour. Toxicology 51: 87-99.